Clinical Trials Map
The results of clinical trials suggest that psychedelics could be used for a range of therapeutic purposes, but figuring out how to participate in psychedelic-assisted therapy as either a therapist or a patient can be complicated. BCSP’s clinical trials map, featuring data from ClinicalTrials.gov, provides a way to navigate past, ongoing and future trials.
Trifecta Research Study
Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Massachusetts General Hospital's Depression and Clinical Research programBoston, Massachusetts, United States
Massachusetts General HospitalBoston, Massachusetts, United States
A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
The Ohio State University Department of PsychiatryColumbus, Ohio, United States
Psilocybin for Major Depressive Disorder (MDD)
University of Alabama Clinical Research UnitBirmingham, Alabama, United States
Preferred Research Partners-NWA, LLCFayetteville, Arkansas, United States
Preferred Research Partners, Inc.Little Rock, Arkansas, United States
Kadima Neuropsychiatry InstituteLa Jolla, California, United States
West LA VA Medical Center – Mental Health DepartmentLos Angeles, California, United States
Pacific Neuroscience Institute (PNI) at Saint John's Physician PartnersSanta Monica, California, United States
Psychedelic Science InstituteSanta Monica, California, United States
Mountain View Clinical ResearchDenver, Colorado, United States
Connecticut Mental Health Center, Yale UniversityNew Haven, Connecticut, United States
Clinical Neuroscience Solutions Inc.Jacksonville, Florida, United States
Innovative Clinical Research, Inc.Lauderhill, Florida, United States
Clinical Neuroscience Solutions, Inc.Orlando, Florida, United States
Emory UniversityAtlanta, Georgia, United States
CenExel iResearch, LLCDecatur, Georgia, United States
Great Lakes Clinical TrialsChicago, Illinois, United States
Johns Hopkins School of Medicine, Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States
Sunstone Medical PCRockville, Maryland, United States
Washington University School of MedicineSt Louis, Missouri, United States
VA Nebraska Western Iowa Health Care SystemOmaha, Nebraska, United States
Global Medical Institutes, LLC; Princeton Medical InstitutePrinceton, New Jersey, United States
University of New Mexico (UNM) Interdisciplinary Substance Use and Brain Injury (ISUBI) CenterAlbuquerque, New Mexico, United States
NYU Clinical & Translational Science InstituteNew York, New York, United States
Bronx Veterans Research Foundation at the James J. Peters VAMCThe Bronx, New York, United States
AIM Trials, LLCPlano, Texas, United States
Clinical Trials of Texas, LLCSan Antonio, Texas, United States
Cedar Clinical ResearchDraper, Utah, United States
Cedar Clinical Research, Inc.Murray, Utah, United States
Seattle Neuropsychiatric Treatment CenterBellevue, Washington, United States
VA Portland Health Care SystemVancouver, Washington, United States
Qualitative Study About Psychedelics Using in Psychiatric Disorders
University Hospital ToulouseToulouse, France
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
UC San DiegoSan Diego, California, United States
Identification of a Safe and Non-Psychedelic Dose of Psilocybin
BioPharma Services Inc.Toronto, Ontario, Canada
Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder
Institute of Health Science, Khyber Medical UniversityIslamabad, Capital, Pakistan
Hayatabad Medical Complex PeshawarPeshawar, KPK, Pakistan
Khyber Medical UniversityPeshawar, KPK, Pakistan
Inhaled DMT for Major Depressive Disorder
Hospital de Saúde Mental Professor Frota PintoFortaleza, Ceará, Brazil
Complexo Hospitalar Universitário Professor Edgard Santos, Federal University of Bahia (HUPES-UFBA)Salvador, Estado de Bahia, Brazil
Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro (IPUB-UFRJ)Rio de Janeiro, Rio de Janeiro, Brazil
Hospital Universitário Onofre Lopes – HUOL – UFRNNatal, Rio Grande do Norte, Brazil
Instituto de Psiquiatria – Hospital das Clínicas – IPq – HC – USPSão Paulo, São Paulo, Brazil
Page 1 of 17
How to use the clinical trials map
Clinical trials have provided growing evidence that ketamine, psilocybin, and MDMA can work in combination with therapy to help alleviate a range of mental disorders, including PTSD, depression, substance-use disorders, and anxiety. The field is advancing rapidly, but it can be difficult to navigate changing information to learn more about specific trials.
In the map view, explore clinical trials based on location. Click on a pink cluster or use the + button to zoom in on a particular location. Click on a smaller pink dot to access an overview of a particular clinical trial, including the substance, the phase, and relevant conditions. Click on the “Full Trial Record” link to learn more about the trial on the ClinicalTrials.gov site.
In the list view, the clinical trials tracker offers a tool for researchers and clinicians to quantify and explore trials based on a number of factors. Click on “Filter” to see relevant trials based on substance, trial status, study phase and more. Where the list shows closed trials users are able explore published results, including searching by institution.